US Stock MarketDetailed Quotes
PFE Pfizer
- 26.270
- -0.050-0.19%
Close Apr 24 16:00 ET
- 26.240
- -0.030-0.11%
Post 19:59 ET
148.75BMarket Cap71.00P/E (TTM)
26.340High26.040Low24.55MVolume26.250Open26.320Pre Close643.82MTurnover0.43%Turnover Ratio71.00P/E (Static)5.66BShares38.80452wk High1.67P/B148.53BFloat Cap25.23052wk Low1.64Dividend TTM5.65BShs Float56.325Historical High6.24%Div YieldTTM1.14%Amplitude5.638Historical Low26.227Avg Price1Lot Size
About Pfizer Company
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Company Profile
SymbolPFE
Company NamePfizer
Listing DateJan 17, 1944
Founded1849
CEODr. Albert Bourla, D.V.M.,PhD
MarketNYSE
Employees88000
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address66 Hudson Boulevard East
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10001-2192
Phone1-212-733-2323
Websitehttp://www.pfizer.com
Company Executives
- Name
- Position
- Salary
- Dr. Albert Bourla, D.V.M.,PhD
- Chairman of the Board and Chief Executive Officer
- 21.56M
- Aamir Malik
- Chief Commercial Officer, U.S. and Executive Vice President
- 5.42M
- Dr. Mikael Dolsten, M.D.,PhD
- Chief Scientific Officer and President, Pfizer Research and Development
- 8.86M
- Rady A. Johnson
- Chief Compliance, Quality and Risk Officer and Executive Vice President
- --
- Michael McDermott
- Executive Vice President and Chief Global Supply Officer
- --
- Alexandre de Germay
- Chief International Commercial Officer and Executive Vice President
- --
- Payal Sahni
- Chief People Experience Officer and Executive Vice President
- --
- Dr. Chris Boshoff, M.D.,PhD
- Executive Vice President and Chief Oncology Officer
- --
- David M. Denton
- Chief Financial Officer and Executive Vice President
- 5.28M
- Sally Susman
- Chief Corporate Affairs Officer and Executive Vice President
- --
- Lidia L. Fonseca
- Chief Digital and Technology Officer and Executive Vice President
- --
- Jennifer B. Damico
- Principal Accounting Officer, Senior Vice President and Controller
- --
- Margaret M. Madden
- Senior Vice President, Corporate Secretary and Chief Governance Counsel
- --
- Douglas M. Lankler
- Executive Vice President and General Counsel
- 5.48M
- Suzanne Nora Johnson
- Independent Director
- 410.00K
- Ronald E. Blaylock
- Independent Director
- 380.00K
- Joseph J. Echevarria
- Independent Director
- 390.00K
- Shantanu Narayen
- Lead Independent Director
- 430.00K
- Dr. Susan J. Hockfield, PhD
- Independent Director
- 363.00K
- Dr. Susan D. Desmond-Hellmann, M.D.,M.P.H.
- Independent Director
- 360.00K
- Dr. Scott Gottlieb,M.D.
- Independent Director
- 417.20K
- Dr. Helen H. Hobbs, M.D.
- Independent Director
- 410.00K
- James Robert Quincey
- Independent Director
- 380.00K
- James C. Smith
- Independent Director
- 390.00K
- Dr. Dan R. Littman, M.D.,PhD
- Independent Director
- 391.40K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
